Basel Medical Group Ltd Ordinary Shares (BMGL) vs Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Cuprina Holdings (Cayman) Limited Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Basel Medical Group Ltd Ordinary Shares logo
BMGL
Basel Medical Group Ltd Ordinary Shares
$5M
$3.23HealthcareDelayed quote: Oct 6, 2026, 3:01 PM EDT
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.11HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT

Total return — BMGL vs CUPR

growth of $100 · dividends reinvested · last 1y
BMGL -94.4% (-94.4%/yr)CUPR -93.2% (-93.2%/yr)CUPR compounded faster over this window
050100150200Start $1002026$6$7
BMGL CUPR

BMGL vs CUPR: by the numbers

  • •CUPR is the larger company ($6M vs $5M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricBMGLCUPR
P/B ratio1.041.44

Profitability

MetricBMGLCUPR
Gross margin77.68%-1.29%
Operating margin-19.28%-9154.62%
Net margin-106.78%-9366.75%
ROE-248.66%-92.44%
ROIC-35.07%-84.15%

Go deeper

Full BMGL analysisFull CUPR analysisInteractive comparison tool

Dig into the metrics

Basel Medical Group Ltd Ordinary Shares ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares ROEBasel Medical Group Ltd Ordinary Shares operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginBasel Medical Group Ltd Ordinary Shares revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.